Sort
10,766 grants matching “checkpoint inhibitor”
Role of PI3Kinase in Tumor Progression and Metastasis
$299,928Judith A. Varner · University Of California, San Diego · R01 · FY2019 · CA
Topic 371 - Phase I SBIR Contract - Valudation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation
$299,847George Martin · Riptide Bioscience, Inc. · N01 · FY2018 · CA
Immunoactivating Peptide AXT201 in Combination with Anti-PD-1 Antibody for Triple-Negative Breast Cancer
$299,815Niranjan B Pandey · Asclepix Therapeutics, Inc. · R43 · FY2019 · CA
Synergistic Anti-tumor Efficacy of an Interleukin 2 Analog and PD-1 blockade
$299,794Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2018 · CA
microRNA-21 Blockade of Triple Negative Breast Cancer
$299,774Eric Wickstrom · Bound Therapeutics, Llc · R41 · FY2019 · CA
Novel diagnostics for autoimmunity from checkpoint inhibitor immune therapy
$299,754Sahar Usmani-Brown · L2 Diagnostics, Llc · R43 · FY2017 · DK
Project 2: Targeting Immune Vulnerabilities in Lung Cancer
$299,724John V. Heymach · Ut Southwestern Medical Center · P50 · FY2021 · CA
HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
$299,709University Of California Los Angeles · R01 · FY2002 · CA
Mitotic Checkpoint Regulators in Insulin Signaling
$299,700Melanie H Cobb · Ut Southwestern Medical Center · R01 · FY2019 · GM
Mitotic Checkpoint Regulators in Insulin Signaling
$299,700Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2018 · GM
Mitotic Checkpoint Regulators in Insulin Signaling
$299,700Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2017 · GM
Mitotic Checkpoint Regulators in Insulin Signaling
$299,700Melanie H Cobb · Ut Southwestern Medical Center · R01 · FY2020 · GM
Roles of Lig3 and XRCC1 Genes in Genome Stability
$299,690Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2012 · ES
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
$299,607Emmanuel T Akporiaye · Veana Therapeutics, Llc · R43 · FY2018 · CA
A Simple Blood Test for Microsatellite Instability Status
$299,593Kathryn Frances Sykes · Calviri, Inc. · R43 · FY2019 · CA
Critical Fluid Nanosomes for Effective Targeted Delivery and Manufacture of siRNA-based Therapeutics
$299,591Trevor Castor · Aphios Corporation · N43 · FY2017 · AI
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$299,472Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2019 · CA
A Self-Replicating RNA Vaccine Against HIV-1 Delivered Using A Nanoparticle Adjuvant
$299,184Amit Khandhar · Pai Life Sciences, Inc. · N43 · FY2019 · AI
Cancer Immunology
$299,086Drew M. Pardoll · Johns Hopkins University · P30 · FY2025 · CA
Flow Cytometry and Technology Development
$299,086Victor M Lemas · Johns Hopkins University · P30 · FY2025 · CA
Structure and Function of the Essential Cell Cycle Regulator Cdc34
$299,000Shaun Olsen · Medical University Of South Carolina · R01 · FY2019 · GM
XLF in double-strand break repair and chemo/radiosensitization
$298,958Lawrence F Povirk · Virginia Commonwealth University · R01 · FY2014 · CA
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
$298,911Mark J. Mamula · L2 Diagnostics, Llc · R41 · FY2020 · AI
Mechanisms that coordinate cell size with mitotic entry
$298,890James B Moseley · Dartmouth College · R01 · FY2016 · GM
Mechanisms that coordinate cell size with mitotic entry
$298,890James B Moseley · Dartmouth College · R01 · FY2014 · GM